公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Biomarker Analyses and Final Overall Survival Results from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/ Paclitaxel in Clinically Selected Patients with Advanced Non-Small-Cell Lung Cancer in Asia (Ipass) | YANG, CHIH-HSIN; CHAO, TSU-YI | JOURNAL OF CLINICAL ONCOLOGY | | | |
2010 | Final Overall Survival Os Results from a Phase Iii, Randomised, Open-Label , First-Line Study of Gefitinib G V Carboplatin/Paclitaxel C/P in Clinically Selected Patients with Advanced Non-Small Cell Lung Cancer Nsclc in Asia Ipass | YANG, CHIH-HSIN | ANNALS OF ONCOLOGY | | | |
2010 | Phase 2 Results of Xl184 in a Cohort of Patients Pts with Advanced Non- Small Cell Lung Cancer Nsclc | YANG, CHIH-HSIN | EJC SUPPLEMENTS | | | |
2011 | Phase 2 Trial of Linifanib (Abt-869) in Patients with Advanced Non-Small Cell Lung Cancer | YANG, CHIH-HSIN | JOURNAL OF THORACIC ONCOLOGY | | | |
2011 | Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non- Small-Cell Lung Cancer: A Randomized, Double-Blind Phase Iii Trial | YANG, CHIH-HSIN | JOURNAL OF CLINICAL ONCOLOGY | | | |
2012 | 氧化壓力引發的粒線體DNA甲基化對細胞存活率之影響 | 楊至心; Yang, Chih-Hsin | | | | |